{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:42:28Z","timestamp":1786977748658,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Heart Center, Leipzig"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammatory heart disease represents an important cause of chronic dilated cardiomyopathy (DCM). Predicting the clinical course of patients with inflammatory cardiomyopathy (iCMP) is difficult, and the prognostic value of current biological markers remains controversial. We tested whether expression of selected microRNAs in endomyocardial biopsies (EMBs) is related to LV functional recovery and clinical events in iCMP patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>EMBs were obtained from patients with iCMP (n = 76) and non-inflammatory DCM (n = 22). A set of six microRNAs implicated in inflammation (miR-155 and miR-146b), heart failure (miR-21 and miR-133a), and endothelial cell (miR-126) and skeletal muscle function (miR-206) was pre-defined. Endomyocardial expression of miR-155 and miR-133a, as quantified by reverse transcription\u2013PCR (RT\u2013PCR), was up-regulated in patients with iCMP as compared with patients with DCM. Levels of miR-133a (R = 0.73, P &amp;lt; 0.01) and miR-155 (R = 0.63, P &amp;lt; 0.01) correlated with inflammatory cell count on EMBs from patients with iCMP. Patients with iCMP and preserved LV function at study entry demonstrated higher expression of miR-133a than patients with reduced LV function. Also, increased expression of miR-133a was associated with less fibrosis and myocyte necrosis on EMB, and LV functional recovery during a mean follow-up of 3.1\u2009years. Importantly, patients with iCMP and miR-133a levels in the upper tertile showed longer survival free of death, malignant arrhythmias, and hospitalizations for heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present study demonstrates that miR-133a levels correlate with macrophage infiltration, cardiac injury, improved LV function, and clinical outcome in patients with iCMP. miR-133a may serve as a potential novel biomarker and therapeutic target in human iCMP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.579","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T01:07:00Z","timestamp":1465780020000},"page":"1442-1451","source":"Crossref","is-referenced-by-count":71,"title":["Endomyocardial miR-133a Levels Correlate with Myocardial Inflammation, Improved Left Ventricular Function, and Clinical Outcome in Patients with Inflammatory Cardiomyopathy"],"prefix":"10.1093","volume":"18","author":[{"given":"Christian","family":"Besler","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Urban","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Watzka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Philipp","family":"Rommel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kandolf","sequence":"additional","affiliation":[{"name":"Institute for Pathology and Neuropathology, Department of Molecular Pathology, University Hospital Tuebingen , Tuebingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[{"name":"Institute for Pathology and Neuropathology, Department of Molecular Pathology, University Hospital Tuebingen , Tuebingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Heart Center, University of Schleswig-Holstein , Luebeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Linke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schuler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lurz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology, University of Leipzig\u2013Heart Center , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"2026011721165116200_ejhf579-bib-0001","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"Kindermann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721165116200_ejhf579-bib-0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.104.1.39","article-title":"Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results","volume":"104","author":"Wojnicz","year":"2001","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0003","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","article-title":"Predictors of outcome in patients with suspected myocarditis","volume":"118","author":"Kindermann","year":"2008","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0004","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"2026011721165116200_ejhf579-bib-0005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","article-title":"A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis","volume":"28","author":"Caforio","year":"2007","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0006","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1093\/eurheartj\/ehu159","article-title":"Gene expression profiling: time to file diagnostic uncertainty in inflammatory heart diseases?","volume":"35","author":"Krasniqi","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carpath.2014.01.004","article-title":"Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis","volume":"23","author":"Youn","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"2026011721165116200_ejhf579-bib-0008","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"K\u00fchl","year":"2005","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0009","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.303549","article-title":"Long noncoding RNAs and microRNAs in cardiovascular pathophysiology","volume":"116","author":"Thum","year":"2015","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","article-title":"MicroRNAs in myocardial infarction","volume":"12","author":"Boon","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026011721165116200_ejhf579-bib-0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCRESAHA.112.267443","article-title":"MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis","volume":"111","author":"Corsten","year":"2012","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-012-1104-4","article-title":"MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148","volume":"70","author":"Hemida","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2026011721165116200_ejhf579-bib-0013","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.25011\/cim.v36i2.19573","article-title":"MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis","volume":"36","author":"He","year":"2013","journal-title":"Clin Invest Med"},{"key":"2026011721165116200_ejhf579-bib-0014","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00705-013-1695-6","article-title":"MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation","volume":"158","author":"Liu","year":"2013","journal-title":"Arch Virol"},{"key":"2026011721165116200_ejhf579-bib-0015","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1007\/s00018-013-1411-4","article-title":"MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1\/2 and Wnt\/\u03b2-catenin signal pathways","volume":"70","author":"Ye","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2026011721165116200_ejhf579-bib-0016","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/mmr.2014.2205","article-title":"MicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy","volume":"10","author":"Xu","year":"2014","journal-title":"Mol Med Rep"},{"key":"2026011721165116200_ejhf579-bib-0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCHEARTFAILURE.114.001475","article-title":"Differential cardiac microRNA expression predicts the clinical course in human enterovirus cardiomyopathy","volume":"8","author":"Kuehl","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026011721165116200_ejhf579-bib-0018","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/emmm.201202318","article-title":"MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways","volume":"5","author":"Cheng","year":"2013","journal-title":"EMBO Mol Med"},{"key":"2026011721165116200_ejhf579-bib-0019","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/eurheartj\/ehv184","article-title":"miR-21 and cardiac fibrosis: another brick in the wall?","volume":"36","author":"Cavarretta","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrm3619","article-title":"Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair","volume":"14","author":"Xin","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026011721165116200_ejhf579-bib-0021","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/CIRCULATIONAHA.112.093906","article-title":"Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity","volume":"126","author":"Jakob","year":"2012","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0022","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCRESAHA.115.306624","article-title":"miR-206 mediates YAP-induced cardiac hypertrophy and survival","volume":"117","author":"Yang","year":"2015","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0023","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease","volume":"3","author":"Corsten","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"2026011721165116200_ejhf579-bib-0024","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0025","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","article-title":"Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance","volume":"122","author":"Yilmaz","year":"2010","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0026","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis","volume":"114","author":"Mahrholdt","year":"2006","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0027","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/eurheartj\/ehp328","article-title":"Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease","volume":"30","author":"Baccouche","year":"2009","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0028","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcmg.2011.11.022","article-title":"Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis","volume":"5","author":"Lurz","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026011721165116200_ejhf579-bib-0029","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","article-title":"Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology","volume":"109","author":"Mahrholdt","year":"2004","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00430-003-0190-1","article-title":"Molecular pathology of inflammatory cardiomyopathy","volume":"193","author":"Klingel","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"2026011721165116200_ejhf579-bib-0031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cardiores.2006.10.026","article-title":"Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility","volume":"73","author":"Adams","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2026011721165116200_ejhf579-bib-0032","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(11)60648-X","article-title":"Myocarditis","volume":"379","author":"Sagar","year":"2012","journal-title":"Lancet"},{"key":"2026011721165116200_ejhf579-bib-0033","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","article-title":"Diagnosis of myocarditis: death of Dallas criteria","volume":"113","author":"Baughman","year":"2006","journal-title":"Circulation"},{"key":"2026011721165116200_ejhf579-bib-0034","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehv321","article-title":"The microRNA-221\/-222 cluster balances the antiviral and inflammatory response in viral myocarditis","volume":"36","author":"Corsten","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvv120","article-title":"Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p","volume":"106","author":"Echavarria","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2026011721165116200_ejhf579-bib-0036","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCRESAHA.115.303252","article-title":"MicroRNA-133 modulates the \u03b21-adrenergic receptor transduction cascade","volume":"115","author":"Castaldi","year":"2014","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0037","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J"},{"key":"2026011721165116200_ejhf579-bib-0038","first-page":"613","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nature"},{"key":"2026011721165116200_ejhf579-bib-0039","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2009.08.136","article-title":"MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes","volume":"389","author":"Horie","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2026011721165116200_ejhf579-bib-0041","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026011721165116200_ejhf579-bib-0042","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J"},{"key":"2026011721165116200_ejhf579-bib-0043","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvp130","article-title":"Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines","volume":"83","author":"Shan","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2026011721165116200_ejhf579-bib-0044","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodelling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ Res"},{"key":"2026011721165116200_ejhf579-bib-0045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jcp.22939","article-title":"MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension","volume":"227","author":"Castoldi","year":"2012","journal-title":"J Cell Physiol"},{"key":"2026011721165116200_ejhf579-bib-0046","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"2026011721165116200_ejhf579-bib-0047","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"2026011721165116200_ejhf579-bib-0048","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehv109","article-title":"Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis","volume":"36","author":"Lorenzen","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721165116200_ejhf579-bib-0049","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cvr\/cvw030","article-title":"MiR-21 promotes fibrosis in an acute cardiac allograft transplantation model","volume":"110","author":"Gupta","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2026011721165116200_ejhf579-bib-0050","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles","volume":"11","author":"van Rooij","year":"2012","journal-title":"Nat Rev Drug Discov"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.579","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.579","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/12\/1442\/66379586\/eurjhf_18_12_1442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/12\/1442\/66379586\/eurjhf_18_12_1442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:18:07Z","timestamp":1768702687000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/12\/1442\/8423101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,6,13]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.579","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,12]]},"published":{"date-parts":[[2016,6,13]]}}}